Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BIOLASE Inc (NASDAQ:BIOL)

1.17
Delayed Data
As of May 26
 -0.01 / -0.85%
Today’s Change
0.80
Today|||52-Week Range
1.98
-16.43%
Year-to-Date
No recent news for BIOLASE Inc.

Today’s Trading

Previous close1.18
Today’s open1.19
Day’s range1.16 - 1.19
Volume20,686
Average volume (3 months)118,957
Market cap$79.5M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+17.14%
Earnings growth (this year)+44.83%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+7.68%
P/E ratioNM
Price/Sales1.64
Price/Book3.58

Competitors

 Today’s
change
Today’s
% change
MLSSMilestone Scientific...0.000.00%
PDEXPro-Dex Inc+0.06+1.10%
ALGNAlign Technology Inc+0.71+0.50%
XRAYDentsply Sirona Inc-0.35-0.55%
Data as of 4:00pm ET, 05/26/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$51.8M
Annual profit (last year)-$15.4M
Net profit margin-29.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Harold C. Flynn
Vice President-
Operations
Richard R. Whipp
Corporate headquarters
Irvine, California

Forecasts